Photo by Nwato
The compound annual growth rate during the period is expected to be 6.94%.
According to Research and Markets, the global breast cancer brachytherapy market is expected to reach US$1.88b by 2035, with a compound annual growth rate (CAGR) of 6.94%.
The industry's expansion has been attributed to factors such as rising rates of breast cancer, advances in brachytherapy technology and an increasing preference for minimally invasive treatment options.
Consistent with this, supportive government funding, initiatives targeting cancer treatments, and expansion of healthcare infrastructure in emerging markets are fueling its growth.
In terms of technology, the high dose rate brachytherapy segment was the highest revenue segment in the global market last year.
Meanwhile, the low-dose rate brachytherapy segment is expected to grow at the fastest CAGR during the forecast period.
Join the Asian Healthcare Magazine Community
Now that you're here…
….There are many ways you can work with us to promote your company and connect with your customers. Our team can help you plan and create print and digital advertising campaigns on this website and in the print magazine.
We can also organize real-life or digital events for you and source thought-leader speakers and industry leaders (who may be your potential partners) to attend your events. We also run a number of awards programs that give you the chance to be recognized for your achievements during the year, and you can join as a participant or sponsor.
Let us help you drive business development through good partnerships!
